Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct:142:44-50.
doi: 10.1016/j.critrevonc.2019.07.012. Epub 2019 Jul 22.

Systemic therapy for brain metastases

Affiliations
Review

Systemic therapy for brain metastases

Jonathan W Rick et al. Crit Rev Oncol Hematol. 2019 Oct.

Abstract

Metastases from cells outside of the central nervous system are the most common cancer found in the brain and are commonly associated with poor prognosis. Although cancer treatment is improving overall, central nervous system metastases are becoming more prevalent and require finesse to properly treat. Physicians must consider the biology of the primary tumor and the complex neurological environment that the metastasis resides in. This can be further complicated by the fact that the practice of cancer management is constantly evolving and therapy that works outside of the blood-brain barrier may not be effective inside of it. Therefore, this review seeks to update the reader on recent advancements made on the three most common sources of brain metastases: lung cancer, breast cancer, and melanoma. Each of these malignancies has been the subject of intriguing and novel avenues of therapy which are reviewed here.

Keywords: Breast cancer; Lung cancer; Melanoma; Metastasis; Systemic therapy.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest

The authors declare no conflict of interest.

References

    1. Davey P, 2002. Brain metastases: treatment options to improve outcomes. CNS Drugs 16, 325–338. (accessed January 1, 2018). http://www.ncbi.nlm.nih.gov/pubmed/11994022. - PubMed
    1. Nieder C, Mehta MP, Geinitz H, Grosu AL, 2018. Prognostic and predictive factors in patients with brain metastases from solid tumors: a review of published nomograms. Crit. Rev. Oncol. Hematol 126, 13–18. 10.1016/j.critrevonc.2018.03.018. - DOI - PubMed
    1. Lassman AB, DeAngelis LM, 2003. Brain metastases. Neurol. Clin 21, 1–23. (accessed January 7, 2018) vii. http://www.ncbi.nlm.nih.gov/pubmed/12690643. - PubMed
    1. Nayak L, Lee EQ, Wen PY, 2012. Epidemiology of brain metastases. Curr. Oncol. Rep 14, 48–54. 10.1007/s11912-011-0203-y. - DOI - PubMed
    1. Sandru A, Voinea S, Panaitescu E, Blidaru A, 2014. Survival rates of patients with metastatic malignant melanoma. J. Med. Life 7, 572–576. (accessed January 20, 2018). http://www.ncbi.nlm.nih.gov/pubmed/25713625. - PMC - PubMed